ASX-listed health tech firm CardieX announced its subsidiary, medical technology company ATCOR, will partner with AI-enabled health tech company Invaryant to conduct joint clinical research on maternal health and cardiovascular disease.
Invaryant's health platform will integrate digital vascular biomarkers gathered from ATCOR's SphygmoCor arterial technology, which measures the central aortic...
Home care and remote patient monitoring platform Current Health offers a technology platform that uses biosensors to monitor a patient's condition at home and identify when they might need help from a clinician.
Best Buy acquired the Boston-based company in 2021, adding to the retail giant's portfolio of remote patient monitoring and senior care companies.
Adam Wolfberg, Current Health's chief...
San Francisco-based Augmedix has progressed from a Google Glass-based clinical documentation startup to a publicly-traded, AI-enabled ambient automation platform that documents patient encounters and generates medical notes that can be transferred to an EHR.
The company, founded in 2012, also provides pre- and post-visit documentation offerings to give providers a more complete digital picture of...
Leaders in the digital health space told MobiHealthNews their predictions about investors' priorities in the coming year and what companies will need to watch out for.
Following 2021's expansive investments and the decrease in funding in 2022, alongside significant layoffs, stakeholders expect funders to be more selective in 2023 – scrutinizing companies' business models and considering whether...
MobiHealthNews spoke with several digital health stakeholders about 2022's funding environment and how it affected digital health startups.
Investments in 2022 decreased drastically compared to the swells of financial capital raised in 2021, and that lack of funding forced companies to rethink their business models.
Read digital health execs' insights on how this year's decreased funding forced...
Employee wellness company Wellable acquired DailyEndorphin, which offers corporate wellness challenges in which employees can set up group fitness or nutrition programs and invite their colleagues to participate.
DailyEndorphin offers challenges for exercise, step count, nutrition, weight and hydration.
Boston-based Wellable will add DailyEndorphins assets to its Wellable Wellness Platform, which...
As 2022 comes to a close, MobiHealthNews asked executives from across the digital health industry about their biggest takeaways from the year.
Check out their insights below on topics ranging from improving health equity to the continued use of virtual healthcare, especially for behavioral and mental health.
Chris Brickler, cofounder and CEO of MyndVR
"It's important not to get comfortable. In...
Telehealth company MediOrbis announced a partnership with Kahun, which offers an AI-enabled digital intake tool that conducts clinical assessments via a chatbot and provides recommendations for further evaluation.
MediOrbis, an Ohio-based multi-specialty telehealth company, offers chronic disease management and remote patient monitoring services, a medical weight loss program, virtual primary...
Allergy testing and treatment company Nectar raised $16.5 million in a Series A funding round led by Harmony Partners, bringing its total equity raise to more than $24 million.
The company's founding partners, Juxtapose and Obvious Ventures, also participated in the round — Obvious Ventures co-built Nectar with the company's current CEO and former AncestryDNA executive Kenneth Chahine.
WHAT THEY...
New legislation would allow for reimbursement of prescribed digital therapeutics under Medicare, which proponents argue could increase access to these emerging treatments. Still, others say it's new technology, and the wrong reimbursement model could tamper innovation and increase patient costs.
The Access to Prescription Digital Therapeutics Act of 2022, introduced in the U.S. Senate in March...
.jpg?itok=ljxmGbyG "Adam Wolfberg, chief medical officer at Current Health")
%5B25%5D copy.jpg?itok=H5cmzlpJ "Ian Shakil, founder, director and chief strategy officer at Augmedix")
